The prevalence of respiratory and chronic obstructive pulmonary disease (COPD) are the main factors driving the rise in ...

Objective Long-term azithromycin treatment effectively prevents acute exacerbations of chronic obstructive pulmonary disease ...

Risk of respiratory disease is greatly heightened for people with bipolar disorder but we are missing opportunities to intervene to improve lung health.

According to a new comprehensive report from The Insight Partners, the global pulmonary drug delivery system market is ...

A long-term real-world study of older adults with COPD shows that initiation of tiotropium is linked to a minimal increase in dementia risk, which is unlikely to outweigh its clinical benefits.

--Regeneron Pharmaceuticals, Inc. and Sanofi today announced that a Phase 3 trial, AERIFY-1, evaluating the investigational use of itepekimab in adults who were former smokers with inadequately ...

TARRYTOWN, N.Y. and PARIS, May 30, 2025 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi today announced that a Phase 3 trial, AERIFY-1, evaluating the investigational use ...

The U.S. Food and Drug Administration has approved GSK's Nucala (mepolizumab) as an add-on maintenance treatment for adult patients with inadequately controlled chronic obstructive pulmonary ...

Nucala stands out as the only approved biologic that has been specifically evaluated in patients whose eosinophilic phenotype is defined by a blood eosinophil count (BEC) threshold as low as ≥ ...

Nucala Becomes First Biologic Approved for COPD with Eosinophilic Inflammation The FDA’s approval of GSK’s Nucala (mepolizumab) introduces the first biologic treatment for patients with chronic ...

3 Siu DCH, Gafni-Lachter L. Addressing Barriers to Chronic Obstructive Pulmonary Disease (COPD) Care: Three Innovative Evidence-Based Approaches: A Review. Int J Chron Obstruct Pulmon Dis. 2024;19 ...

Snell N., et al (2016) Epidemiology of chronic obstructive pulmonary disease (COPD) in the UK: Findings from the British Lung Foundation’s ‘respiratory health of the nation’ project.